These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7212742)

  • 1. Anti-pigment-cell factors and mucocutaneous candidiasis.
    Nordlund JJ; Howanitz N; Bystryn JC; Forget BM; Lerner AB
    Arch Dermatol; 1981 Apr; 117(4):210-2. PubMed ID: 7212742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to melanocytes. Occurrence in patients with vitiligo and chronic mucocutaneous candidiasis.
    Howanitz N; Nordlund JL; Lerner AB; Bystryn JC
    Arch Dermatol; 1981 Nov; 117(11):705-8. PubMed ID: 7316530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressor T cells role in the unresponsiveness to Candida albicans in chronic mucocutaneous candidiasis.
    Barnaba V; Zaccari C; Levrero M; Balsano F
    Boll Ist Sieroter Milan; 1985; 64(2):126-30. PubMed ID: 3161525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement-fixing activity to melanin-producing cells preceding the onset of vitiligo in a patient with type 1 polyglandular failure.
    Betterle C; Caretto A; Pedini B; Rigon F; Bertoli P; Peserico A
    Arch Dermatol; 1992 Jan; 128(1):123-4. PubMed ID: 1739282
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chronic mucocutaneous candidiasis. Cutaneous expression of immunologic anomalies. Report of a case].
    Pérez Suárez de Durandeau L; Salinas Carmona MC; Silva Siwady JG; Hinojosa Ayala JR
    Med Cutan Ibero Lat Am; 1986; 14(5):357-63. PubMed ID: 3543557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological studies in chronic mucocutaneous candidiasis before and after ketoconazole treatment.
    Mobacken H; Lindholm L; Moberg S
    Acta Derm Venereol; 1987; 67(3):257-60. PubMed ID: 2442942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymoma and late onset mucocutaneous candidiasis associated with a plasma inhibitor of cell-mediated immune function.
    Gatenby P; Basten A; Adams E
    J Clin Lab Immunol; 1980 May; 3(3):209-16. PubMed ID: 7420408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An unusual combination of immunologic abnormalities in a patient with chronic mucocutaneous candidiasis.
    Gill FF; Portnoy JM
    Ann Allergy; 1989 Aug; 63(2):98-100, 147-8. PubMed ID: 2669569
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mucocutaneous candidiasis in an immunosuppressed patient].
    Ragni G; Giampaoli T
    Riv Ital Stomatol; 1982; 51(4):369-72. PubMed ID: 6960454
    [No Abstract]   [Full Text] [Related]  

  • 10. Host factors in defense against fungal infections.
    Kirkpatrick CH
    Am J Med; 1984 Oct; 77(4D):1-12. PubMed ID: 6388323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phagocytic activity of the neutrophilic granulocytes of patients with chronic generalized (granulomatous) candidiasis].
    Stepanova ZhV; Kurshakova TS
    Vestn Dermatol Venerol; 1986; (1):61-4. PubMed ID: 3962491
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic mucocutaneous candidosis. An update.
    Jorizzo JL
    Arch Dermatol; 1982 Dec; 118(12):963-5. PubMed ID: 7149752
    [No Abstract]   [Full Text] [Related]  

  • 13. Dermatological manifestations of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome.
    Collins SM; Dominguez M; Ilmarinen T; Costigan C; Irvine AD
    Br J Dermatol; 2006 Jun; 154(6):1088-93. PubMed ID: 16704638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of chronic mucocutaneous candidiasis with 5-fluorocytosine.
    Lin CY
    Ann Allergy; 1982 Nov; 49(5):298-300. PubMed ID: 6756218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candidiasis-endocrinopathy syndrome with progressive myopathy.
    Evans RA; Carter JN; Shenston B; Smith A; Hills E; Walls R; Corbett A
    Q J Med; 1989 Feb; 70(262):139-44. PubMed ID: 2594954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer (NK) cells in mucocutaneous candidiasis.
    Palma-Carlos AG; Palma-Carlos ML; da Silva SL
    Allerg Immunol (Paris); 2002 Jun; 34(6):208-12. PubMed ID: 12134644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic mucocutaneous candida mycosis (CMCC) caused by a T-cell defect].
    Rytter M; Schönborn C; Lohrisch I; Haustein UF
    Z Gesamte Inn Med; 1986 Apr; 41(7):214-6. PubMed ID: 3521108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired generation of helper T cells in a patient with chronic mucocutaneous candidiasis and malignant thymoma.
    Ruiz-Argüelles A; Jett JR; Ritts RE
    J Clin Lab Immunol; 1983 Mar; 10(3):165-9. PubMed ID: 6221110
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic mucocutaneous candidiasis.
    Kirkpatrick CH
    Eur J Clin Microbiol Infect Dis; 1989 May; 8(5):448-56. PubMed ID: 2502409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Familial chronic mucocutaneous candidiasis associated with autoimmune polyendocrinopathy. Treatment with fluconazole: 3 cases].
    Rybojad M; Abimelec P; Feuilhade M; Morel P; Bourrat E
    Ann Dermatol Venereol; 1999 Jan; 126(1):54-6. PubMed ID: 10095896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.